Substituted pyrrolidines as G-protein coupled receptor 43 agonists

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9695120
APP PUB NO 20130023539A1
SERIAL NO

13526337

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to novel pyrrolidine carboxylic acid derivatives, pharmaceutical compositions, and their use in treating and/or preventing metabolic diseases as agonists of g-protein coupled receptor 43.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
EPICS THERAPEUTICSRUE ADRIENNE BOLLAND 47 GOSSELIES 6041

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hoveyda, Hamid R Brussels, BE 42 506
Parcq, Julien Lille, FR 15 4
Schils, Didier Loupoigne, BE 8 7
Zoute, Ludivine Vedrin, BE 9 8

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 4, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00